Back to top
more

Olink Holding (OLK)

(Real Time Quote from BATS)

$23.06 USD

23.06
39,859

-0.29 (-1.24%)

Updated Apr 30, 2024 01:18 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value D Growth D Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 38% (95 out of 251)

Industry: Medical Info Systems

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

ImmunoPrecise Antibodies Ltd. (IPA) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

ImmunoPrecise Antibodies Ltd. (IPA) delivered earnings and revenue surprises of 0% and 3.93%, respectively, for the quarter ended January 2024. Do the numbers hold clues to what lies ahead for the stock?

Senseonics Holdings (SENS) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

Senseonics (SENS) delivered earnings and revenue surprises of 25% and 4.99%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Company News for Nov 16, 2023

by Zacks Equity Research

Companies In The News Are: ALC, XPEV, OLK, AAP.

Tivic Health Systems, Inc. (TIVC) Reports Q3 Loss, Misses Revenue Estimates

by Zacks Equity Research

Tivic Health Systems, Inc. (TIVC) delivered earnings and revenue surprises of 78.86% and 63.85%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Why Earnings Season Could Be Great for Olink (OLK)

by Zacks Equity Research

Olink (OLK) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Analysts Estimate Olink Holding AB (publ) Sponsored ADR (OLK) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Olink Holding AB (publ) Sponsored ADR (OLK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Strength Seen in Olink Holding AB (publ) Sponsored ADR (OLK): Can Its 66.0% Jump Turn into More Strength?

by Zacks Equity Research

Olink Holding AB (publ) Sponsored ADR (OLK) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Olink Holding AB (publ) Sponsored ADR (OLK) Reports Q2 Loss, Misses Revenue Estimates

by Zacks Equity Research

Olink Holding AB (publ) Sponsored ADR (OLK) delivered earnings and revenue surprises of 22.22% and 12.11%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Clover Health Investments, Corp. (CLOV) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

Clover Health Investments, Corp. (CLOV) delivered earnings and revenue surprises of 53.85% and 1.41%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Wall Street Analysts Believe Olink Holding AB (publ) Sponsored ADR (OLK) Could Rally 31.22%: Here's is How to Trade

by Zacks Equity Research

The average of price targets set by Wall Street analysts indicates a potential upside of 31.2% in Olink Holding AB (publ) Sponsored ADR (OLK). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Olink Holding AB (publ) Sponsored ADR (OLK) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

Olink Holding AB (publ) Sponsored ADR (OLK) delivered earnings and revenue surprises of 8.33% and 0.71%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Motus GI Holdings, Inc. (MOTS) Reports Q1 Loss, Lags Revenue Estimates

by Zacks Equity Research

Motus GI Holdings, Inc. (MOTS) delivered earnings and revenue surprises of 38.68% and 88.80%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

SOPHiA GENETICS SA (SOPH) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

SOPHiA GENETICS SA (SOPH) delivered earnings and revenue surprises of -10.71% and 4.14%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Enovis (ENOV) Q1 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Enovis (ENOV) delivered earnings and revenue surprises of 18.92% and 4.12%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Olink Holding AB (publ) Sponsored ADR (OLK) Moves to Strong Buy: Rationale Behind the Upgrade

by Zacks Equity Research

Olink Holding AB (publ) Sponsored ADR (OLK) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Industry Outlook Highlights Inspire Medical Systems, Olink Holding and Health Catalyst

by Zacks Equity Research

Inspire Medical Systems, Olink Holding and Health Catalyst have been highlighted in this Industry Outlook article.

Urmimala Biswas headshot

3 Medical Info Systems Stocks Countering Industry-wide Headwinds

by Urmimala Biswas

Zacks Medical Info Systems industry stocks like Inspire Medical Systems (INSP), Olink Holding (OLK) and Health Catalyst (HCAT) are expected to gain even as COVID-19 severity fades.

Olink Holding AB (publ) Sponsored ADR (OLK) Beats Q4 Earnings and Revenue Estimates

by Zacks Equity Research

Olink Holding AB (publ) Sponsored ADR (OLK) delivered earnings and revenue surprises of 25% and 0.22%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Olink Holding AB (publ) Sponsored ADR (OLK) to Report Q4 Results: Wall Street Expects Earnings Growth

by Zacks Equity Research

Olink Holding AB (publ) Sponsored ADR (OLK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Indrajit Bandyopadhyay headshot

5 Winning Medical Product Stocks That Still Have Room to Run

by Indrajit Bandyopadhyay

Despite ongoing macro challenges, medical product stocks like Cardinal Health (CAH), TransMedics Group (TMDX), Olink Holding (OLK), Silk Road Medical (SILK) and Neuronetics (STIM) are likely to gain from strong fundamentals.

Is Olink Holding (OLK) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Here is how Olink Holding AB publ Sponsored ADR (OLK) and Oncolytics Biotech Inc. (ONCY) have performed compared to their sector so far this year.

Zacks.com featured highlights MacroGenics, Olink Holding, NerdWallet, LiveRamp and LivePerson

by Zacks Equity Research

MacroGenics, Olink Holding, NerdWallet, LiveRamp and LivePerson have been highlighted in this Screen of The Week article.

Tirthankar Chakraborty headshot

5 Best Stocks to Invest in for Solid Earnings Acceleration

by Tirthankar Chakraborty

Invest in stocks like MacroGenics (MGNX), NerdWallet (NRDS) & LivePerson (LPSN) at the moment for superb earnings acceleration.

Olink Holding AB publ Sponsored ADR (OLK) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

Olink Holding AB publ Sponsored ADR (OLK) delivered earnings and revenue surprises of 91.67% and 9.15%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Sonendo, Inc. (SONX) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

Sonendo, Inc. (SONX) delivered earnings and revenue surprises of -20.51% and 7.43%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?